Results 1 to 10 of about 204,881 (211)

National immunisation campaigns with oral polio vaccine may reduce all-cause mortality: Analysis of 2004–2019 demographic surveillance data in rural Bangladesh

EClinicalMedicine, 2021
Background: West African studies have suggested that national immunisation campaigns with oral polio vaccine (C-OPV) may non-specifically reduce all-cause child mortality rate by 15–25%.
Sebastian Nielsen, Md.Abdul Khalek, Christine Stabell Benn, Peter Aaby, Syed Manzoor Ahmed Hanifi   +4 more
doaj   +1 more source

Oral Polio Vaccine Campaigns May Reduce the Risk of Death from Respiratory Infections

Vaccines, 2021
Oral polio vaccine (OPV) campaigns, but not other campaigns, have been associated with major reductions in child mortality. Studies have shown that OPV reduces the risk of respiratory infections.
Sebastian Nielsen, Hasan Mahmud Sujan, Christine Stabell Benn, Peter Aaby, Syed Manzoor Ahmed Hanifi   +4 more
doaj   +1 more source

Health effects of utilising hospital contacts to provide measles vaccination to children 9–59 months—a randomised controlled trial in Guinea-Bissau

Trials, 2022
Background Measles vaccination coverage in Guinea-Bissau is low; fewer than 80% of children are currently measles vaccinated before 12 months of age. The low coverage hampers control of measles.
Ane B. Fisker, Justiniano S. D. Martins, Andreas M. Jensen, Cesario Martins, Peter Aaby, Sanne M. Thysen   +5 more
doaj   +1 more source

One vaccine to counter many diseases? Modeling the economics of oral polio vaccine against child mortality and COVID-19

Frontiers in Public Health, 2022
IntroductionRecent reviews summarize evidence that some vaccines have heterologous or non-specific effects (NSE), potentially offering protection against multiple pathogens.
Angela Y. Chang, Angela Y. Chang, Peter Aaby, Peter Aaby, Michael S. Avidan, Christine S. Benn, Christine S. Benn, Christine S. Benn, Stefano M. Bertozzi, Stefano M. Bertozzi, Stefano M. Bertozzi, Lawrence Blatt, Lawrence Blatt, Konstantin Chumakov, Konstantin Chumakov, Shabaana A. Khader, Shyam Kottilil, Shyam Kottilil, Madhav Nekkar, Mihai G. Netea, Mihai G. Netea, Mihai G. Netea, Annie Sparrow, Dean T. Jamison   +23 more
doaj   +1 more source

Randomized clinical trials of COVID-19 vaccines: Do adenovirus-vector vaccines have beneficial non-specific effects?

iScience, 2023
Summary: We examined the possible non-specific effects of novel mRNA- and adenovirus-vector COVID-19 vaccines by reviewing the randomized control trials (RCTs) of mRNA and adenovirus-vector COVID-19 vaccines. We calculated mortality risk ratios (RRs) for
Christine S. Benn, Frederik Schaltz-Buchholzer, Sebastian Nielsen, Mihai G. Netea, Peter Aaby   +4 more
doaj   +1 more source

Effect of national immunisation campaigns with oral polio vaccine on all-cause mortality in children in rural northern Ghana: 20 years of demographic surveillance cohort dataResearch in context

EClinicalMedicine, 2023
Summary: Background: Studies from Guinea-Bissau and Bangladesh have shown that campaigns with oral polio vaccine (C-OPV) may be associated with 25–31% lower child mortality. Between 1996 and 2015, Ghana had 50 national C-OPVs and numerous campaigns with
Paul Welaga, Martin Kavao Mutua, Syed Manzoor Ahmed Hanifi, Patrick Ansah, Peter Aaby, Sebastian Nielsen   +5 more
doaj   +1 more source

Parental Bacillus Calmette-Guérin vaccine scars decrease infant mortality in the first six weeks of life: A retrospective cohort study

EClinicalMedicine, 2021
Background: Live attenuated vaccines have been observed to have particularly beneficial effects for child survival when given in the presence of maternally transferred immunity (priming).
MLT Berendsen, F. Schaltz-Buchholzer, P. Bles, S. Biering-Sørensen, KJ. Jensen, I. Monteiro, I. Silva, P. Aaby, CS. Benn   +8 more
doaj   +1 more source

Is early measles vaccination associated with stronger survival benefits than later measles vaccination?

BMC Public Health, 2018
Background Measles vaccine (MV) may protect against non-measles mortality. We tested whether survival depended on age of measles vaccination. Methods Bandim Health Project follows children under 5 years of age through a Health and Demographic ...
Jesper Sloth Hansen, Sanne Marie Thysen, Amabelia Rodrigues, Cesario Martins, Ane Bærent Fisker   +4 more
doaj   +1 more source

Harnessing the non-specific immunogenic effects of available vaccines to combat COVID-19

Human Vaccines & Immunotherapeutics, 2021
No proven remedy is identified for COVID-19 yet. SARS-CoV-2, the viral agent, is recognized by some endosomal and cytosolic receptors following cell entry, entailing innate and adaptive immunity stimulation, notably through interferon induction ...
Pouria Mosaddeghi, Farbod Shahabinezhad, Mohammadreza Dorvash, Mojtaba Goodarzi, Manica Negahdaripour   +4 more
doaj   +1 more source

Measles Vaccination Supports Millennium Development Goal 4: Increasing Coverage and Increasing Child Survival in Northern Ghana, 1996–2012

Frontiers in Public Health, 2018
BackgroundMeasles vaccine (MV) administered as the last vaccine after the third dose of diphtheria-tetanus-pertussis (DTP) may be associated with better child survival unrelated to prevention of measles infection.
Paul Welaga, Paul Welaga, Abraham Hodgson, Cornelius Debpuur, Peter Aaby, Peter Aaby, Fred Binka, Daniel Azongo, Abraham Oduro   +8 more
doaj   +1 more source